紐約時報報導研究指輝瑞第 3 劑疫苗對年長人仕的保護只增強至少 12 天, 其後發覺不妥立即改文增強幾星期😂

 紐約時報報導以色列研究指輝瑞第 3 劑疫苗對年長人仕的保護只增強至少 12 天, 其後發覺不妥立即改文增強幾星期😂

The New York Times

紐約時報

舊版:

Study of Booster Shot Benefits Fans Debate Over Extra Doses

加强劑得益的研究激起額㚈劑量的辯論

Researchers in Israel reported that a third dose of the Pfizer-BioNTech Covid vaccine can enhance protection in adults older than 60 for at least 12 days a result that is unsurprising, experts said, and does not indicate long term benefit.

以色列的研究人員報告第三劑輝瑞-BioNTech 新冠疫苗可對 60 歲以上成年人的保護增強至少 12 天。這結果專家說毫不令人驚奇，及沒標明長期得益

新版:

New Study of Covid Booster Shots Fans Debate Over Benefits

冠狀病毒疫苗加强劑的新研究激起益處的爭論

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

包括政府科學家在內的獨立專家都對來自以色列的研究持懷疑態度，其中包括有限的短期數據 (註: 110萬60歲以上人仕, 比現存任何一款疫苗的數據為多lol)

https://www.nytimes.com/2021/09/15/health/covid-booster-shot-data.html